Prime Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Prime Medicine (Nasdaq: PRME) said management will participate in three investor conferences in early March 2026: TD Cowen (fireside chat, Mar 4, 2026, 1:10 p.m. ET, Boston), Jefferies Biotech on the Beach (1x1 meetings, Mar 10, 2026, Miami Beach) and Citizens Life Sciences (fireside chat, Mar 11, 2026, 2:15 p.m. ET, Miami Beach).

Live audio webcasts of the fireside chats will be available under Events & Presentations on the company website, with replays accessible for 90 days.

CAMBRIDGE, Mass., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that company management will participate in three upcoming conferences:

• TD Cowen 46^th Annual Health Care Conference: Fireside chat on Wednesday, March 4, 2026, at 1:10 p.m. ET in Boston, MA.
• 2026 Jefferies Biotech on the Beach Summit: Company management will host 1x1 meetings on Tuesday, March 10, 2026, in Miami Beach, FL.
• The Citizens Life Sciences Conference: Fireside chat on Wednesday, March 11, 2026, at 2:15 p.m. ET in Miami Beach, FL.
  
  

Live audio webcasts of the fireside chats will be available under “Events & Presentations” in the News & Events section of the Company’s website at www.primemedicine.com. Replays of each webcast will be available on the Prime Medicine website for 90 days following the event.

About Prime Medicine

Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is deploying its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. Designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications, Prime Editors have the potential to repair almost all types of genetic mutations and work in many different tissues, organs and cell types. Taken together, Prime Editing’s versatile gene editing capabilities could unlock opportunities across thousands of potential indications.

Prime Medicine is currently progressing a diversified portfolio of investigational therapeutic programs organized around our core areas of focus: liver, lung, and immunology and oncology. Across each core area, Prime Medicine is focused initially on a set of high value programs, each targeting a disease with well-understood biology and a clearly defined clinical development and regulatory path, and each expected to provide the foundation for expansion into additional opportunities. Over time, the Company intends to maximize Prime Editing’s broad and versatile therapeutic potential, as well as the modularity of the Prime Editing platform, to rapidly and efficiently expand beyond the diseases in its current pipeline, potentially including additional genetic diseases, immunological diseases, cancers, infectious diseases, and targeting genetic risk factors in common diseases, which collectively impact millions of people. For more information, please visit www.primemedicine.com.

© 2026 Prime Medicine, Inc. All rights reserved. PRIME MEDICINE, the Prime Medicine logos, and PASSIGE are trademarks of Prime Medicine, Inc. All other trademarks referred to herein are the property of their respective owners.

Investor and Media Contacts

Gregory Dearborn
Prime Medicine
857-209-0696
gdearborn@primemedicine.com 

Hannah Deresiewicz
Precision AQ
212-362-1200
hannah.deresiewicz@precisionaq.com

FAQ

When will Prime Medicine (PRME) present at the TD Cowen 46th Annual Health Care Conference?

Prime Medicine will present on Wednesday, March 4, 2026 at 1:10 p.m. ET. According to the company, this event will be a fireside chat in Boston and will be available via live audio webcast under Events & Presentations on the company website.

How can investors listen to Prime Medicine (PRME) fireside chats on March 4 and March 11, 2026?

Investors can join live audio webcasts via the company website's Events & Presentations section. According to the company, replays of each webcast will be available on the Prime Medicine website for 90 days following each event.

What is Prime Medicine (PRME) schedule at the 2026 Jefferies Biotech on the Beach Summit?

Prime Medicine will host one-on-one meetings on Tuesday, March 10, 2026 in Miami Beach. According to the company, management plans 1x1 investor meetings rather than a public fireside chat at that summit.

What time is Prime Medicine (PRME) scheduled for the Citizens Life Sciences Conference fireside chat?

The fireside chat is scheduled for Wednesday, March 11, 2026 at 2:15 p.m. ET. According to the company, the session will be in Miami Beach and an audio webcast will be posted on the company's Events & Presentations page.

Where will Prime Medicine (PRME) host webcasts and how long will replays remain available after the March 2026 events?

Webcasts and replays will be hosted under Events & Presentations on the company website. According to the company, replays of each webcast will remain accessible on the Prime Medicine website for 90 days after each event.